David S Weinberg, MD, MSc

Department of Medicine

Chair, Department of Medicine

Meet other members of the gastrointestinal treatment team.

Meet other members of the gastroenterology department.

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111-2497

To make an appointment, call:
215-214-1475.

For general information, call:
1-888-FOX CHASE.
An oncology certified nurse will assist you.

Clinical Expertise:

Gastroenterology; Molecular Epidemiology of Gastrointestinal Disease; Gastrointestinal Cancer Screening and Prevention

Medical Education:

Cornell University Medical College, Ithaca, N.Y., 1989
(M.Sc. in Cancer Epidemiology, University of Pennsylvania, Philadelphia, Pa.,1997)

Residency:

Internal Medicine, Beth Israel Hospital, Boston, Mass.

Fellowships:

Gastroenterology, University of Pennsylvania, Philadelphia, Pa.;
Clinical Epidemiology, University of Pennsylvania, Philadelphia, Pa.

Certifications:

American Board of Internal Medicine;
Gastroenterology

Professional Societies:

American Association for Cancer Research;
American Gastroenterological Association, Fellow;
The American College of Gastroenterology;
National Institutes of Health, Member, Clinical Oncology Emphasis Panel

Scientific Report:

Gastroenterology Program;
Medical Oncology: Clinical Trials Research
(These links require Adobe® Acrobat Reader to view.)

Research Interests:

Cancer Risk Assessment and Prevention;
Principal Investigator Directory

I joined the staff at Fox Chase Cancer Center in 2001 as director of gastroenterology. While my gastroenterology colleagues and I see many patients with cancers of all types, we are very happy to care for the gastrointestinal needs of patients without cancer as well.

I have a special interest in cancer prevention, especially for patients who are at average risk for gastrointestinal cancers. The current methods of gastrointestinal cancer prevention tools, like colonoscopy, are very effective. However, it is very likely that the next generation of screening techniques will be substantially better. Finding new ways to increase participation in screening programs and to use molecular or genetic markers to provide more accurate estimates of risk are particular interests of mine. Hopefully, finding such markers will allow for better targeting of screening and other risk reduction strategies now and in the future.